Page last updated: 2024-08-21

hydrazine and Adenocarcinoma, Clear Cell

hydrazine has been researched along with Adenocarcinoma, Clear Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, X; Choi, JS; Gershenson, DM; Izaguirre, DI; Kwan, HS; Kwan, SY; Tsang, YT; Wong, KK	1

Other Studies

1 other study(ies) available for hydrazine and Adenocarcinoma, Clear Cell

Article	Year
Loss of ARID1A expression leads to sensitivity to ROS-inducing agent elesclomol in gynecologic cancer cells. Oncotarget, 2016, Aug-30, Volume: 7, Issue:35 Topics: Adenocarcinoma, Clear Cell; Apoptosis; Cell Line, Tumor; Cell Proliferation; DNA-Binding Proteins; Female; Gene Expression Regulation, Neoplastic; Genomics; Humans; Hydrazines; Inhibitory Concentration 50; Mutation; Nuclear Proteins; Ovarian Neoplasms; Oxidative Stress; Reactive Oxygen Species; RNA, Small Interfering; Transcription Factors	2016

Article

Year

Loss of ARID1A expression leads to sensitivity to ROS-inducing agent elesclomol in gynecologic cancer cells.

Oncotarget, 2016, Aug-30, Volume: 7, Issue:35

Topics: Adenocarcinoma, Clear Cell; Apoptosis; Cell Line, Tumor; Cell Proliferation; DNA-Binding Proteins; Female; Gene Expression Regulation, Neoplastic; Genomics; Humans; Hydrazines; Inhibitory Concentration 50; Mutation; Nuclear Proteins; Ovarian Neoplasms; Oxidative Stress; Reactive Oxygen Species; RNA, Small Interfering; Transcription Factors

2016